← Back
Data updated: Mar 10, 2026
BRACCO
CardiovascularOncologyMetabolic
BRACCO is a specialty pharmaceutical company focused on Cardiovascular, Oncology, Metabolic. Key products include LUMASON.
1954
Since
67
Drugs
-
Trials
23
Approved (2yr)
Key Drugs
Recent Activity
ISOVUE-370 2026-01-13
Labeling
ISOVUE-250 2026-01-13
Labeling
THALLOUS CHLORIDE TL 201 2025-12-10
Labeling
ISOVUE-250 2025-10-10
Labeling
ISOVUE-250 2025-10-10
Efficacy
E-Z-DISK 2025-08-01
Type 7 - Drug Already Marketed without Approved NDA
PHOSPHOTEC 2025-05-22
Labeling
MULTIHANCE 2025-03-05
Labeling
PROHANCE 2025-03-05
Labeling
MULTIHANCE MULTIPACK 2025-03-05
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 50%
0 drugs Phase 3: 2
Oncology 38%
0 drugs Phase 2: 3
Metabolic 6%
0 drugs Phase 1: 1
Respiratory 6%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Competitors Pro
AstraZeneca big-pharma
Oncology, Respiratory, Cardiovascular, Metabolic
Novartis big-pharma
Oncology, Cardiovascular, Respiratory
Boehringer Ingelheim big-pharma
Metabolic, Oncology, Respiratory, Cardiovascular
Merck big-pharma
Oncology, Cardiovascular, Metabolic
Johnson & Johnson big-pharma
Oncology, Cardiovascular, Metabolic
Active (29)
E-Z-DISK VARIBAR PUDDING VARIBAR HONEY TAGITOL V LIQUID E-Z-PAQUE READI-CAT 2 ENTERO VU 24% VARIBAR THIN HONEY VARIBAR NECTAR READI-CAT 2 SMOOTHIE E-Z-HD VARIBAR THIN LIQUID E-Z-PAQUE LUMASON MULTIHANCE MULTIHANCE MULTIPACK PROHANCE MULTIPACK PROHANCE CARDIOGEN-82 CHOLETEC ISOVUE-370 ISOVUE-300 ISOVUE-M 200 ISOVUE-M 300 THALLOUS CHLORIDE TL 201 KINEVAC GASTROGRAFIN CYSTOGRAFIN CYSTOGRAFIN DILUTE
Discontinued (38)
ISOVUE-250 ISOVUE-200 ISOVUE-128 PHOSPHOTEC IOMERVU E-Z-CAT DRY CHOLOGRAFIN MEGLUMINE CHOLOGRAFIN SODIUM RENOGRAFIN-76 RENO-60 RENOGRAFIN-60 RENOVIST RENO-DIP RENOVIST II DIATRIZOATE MEGLUMINE RENO-30 SINOGRAFIN RENOVUE-DIP ROBENGATOPE TESULOID RENOTEC RENOVUE-65 HIPPUTOPE MINITEC CARDIOTEC RENOCAL-76 IODOTOPE MACROTEC CHROMITOPE SODIUM SONORX LUMENHANCE CHOLOVUE ORAGRAFIN SODIUM ORAGRAFIN CALCIUM CARDIOGRAFIN SETHOTOPE PHOSPHOTOPE CHLORMERODRIN HG 197
Company Info
- First Approval
- 1954-04-27
- Latest
- 2026-01-13
- Applications
- 44